Jazz Pharmaceuticals
JAZZ
JAZZ
417 hedge funds and large institutions have $6.52B invested in Jazz Pharmaceuticals in 2018 Q4 according to their latest regulatory filings, with 83 funds opening new positions, 155 increasing their positions, 128 reducing their positions, and 65 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
less ownership
Funds ownership: →
30% less capital invested
Capital invested by funds: $9.33B → $6.52B (-$2.81B)
31% less call options, than puts
Call options by funds: $18M | Put options by funds: $26.1M
44% less funds holding in top 10
Funds holding in top 10: 9 → 5 (-4)
Holders
417
Holding in Top 10
5
Calls
$18M
Puts
$26.1M
Top Buyers
| 1 | +$57.8M | |
| 2 | +$54.7M | |
| 3 | +$40.9M | |
| 4 |
CTA
Carillon Tower Advisers
St. Petersburg,
Florida
|
+$37.6M |
| 5 |
Renaissance Technologies
New York
|
+$31.5M |
Top Sellers
| 1 | -$161M | |
| 2 | -$154M | |
| 3 | -$149M | |
| 4 |
Fidelity Investments
Boston,
Massachusetts
|
-$143M |
| 5 |
AII
AGF Investments Inc
Toronto,
Ontario, Canada
|
-$77.1M |